COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA

Autoři

PAGANO Livio SALMANTON-GARCÍA Jon MARCHESI Francesco LÓPEZ-GARCÍA Alberto LAMURE Sylvain ITRI Federico GOMES-SILVA Maria DRAGONETTI Giulia FALCES-ROMERO Iker DOESUM Jaap van SILI Uluhan LABRADOR Jorge CALBACHO Maria BILGIN Yavuz M WEINBERGEROVÁ Barbora SERRANO Laura SUSANA José-María Ribera-Santa MALAK Sandra LOUREIRO-AMIGO José GLENTHOJ Andreas CÓRDOBA-MASCUNANO Raúl NUNES-RODRIGUES Raquel GONZÁLEZ-LÓPEZ Tomás-José KARLSSON Linda Katharina JIMÉNEZ-LORENZO María-Josefa HERNÁNDEZ-RIVAS José-Ángel JAKSIC Ozren RÁČIL Zdeněk BUSCA Alessandro CORRADINI Paolo HOENIGL Martin KLIMKO Nikolai KOEHLER Philipp PAGLIUCA Antonio PASSAMONTI Francesco CORNELY Oliver A

Rok publikování 2022
Druh Článek v odborném periodiku
Časopis / Zdroj Blood
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
www https://ashpublications.org/blood/article/139/10/1588/477881/COVID-19-in-vaccinated-adult-patients-with
Doi http://dx.doi.org/10.1182/blood.2021014124
Klíčová slova COVID-19; patients with hematological malignancies; vaccination; EPICOVIDEHA
Popis Coronavirus disease 2019 (COVID-19) is a life-threatening condition of high relevance for comorbid patients, such as those with baseline hematological malignancies (HM). In April 2020, the European Hematology Association - Infectious Diseases Working Party opened an open web-based registry to collect all cases of HM adult patients that developed COVID-19 infections (EPICOVIDEHA survey). This registry aimed to describe the epidemiology, risk factors, and mortality rates of HM patients. Overall, we collected 3801 valid cases, and we observed an overall mortality rate of 31%.

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info